$HDSN Balance Sheet | Understand Stock

$HDSN

$5.25 -$0.02 (0.29%) Live

$HDSN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Trade accounts receivable - net of allowance for credit losses of $1,214 and $941, respectively
Inventories
Income tax receivable
Prepaid expenses and other current assets
Total current assets
Property, plant and equipment, less accumulated depreciation
Goodwill
Intangible assets, less accumulated amortization
Right of use assets
Other assets
Total Assets
Liabilities and Stockholders' Equity
Current liabilities:
Trade accounts payable
Accounts payable
Accrued expenses and other current liabilities
Accrued payroll
Cylinder Deposit Liability
Current maturities of long-term debt
Short-term debt
Other short-term liabilities
Total current liabilities

Deferred tax liability
Long-term lease liabilities
Long-term debt, less current maturities, net of deferred financing costs
Long-term severance payable
Other long-term liabilities
Total Liabilities
Stockholders' equity:
Preferred stock, shares authorized 5,000,000: Series A Convertible preferred stock, $0.01 par value ($100 liquidation preference value); shares authorized 150,000; none issued or outstanding
Common stock, $0.01 par value; shares authorized 100,000,000; issued and outstanding: 42,088,547 and 41,647,221, respectively
Additional paid-in capital
Retained earnings
Total Stockholders' Equity

Total Liabilities and Stockholders' Equity

Comments